Placental growth factor (PlGF): a key to optimizing fetal growth

References

• Torry RJ, Rongish BJ. Angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis. Am J Reprod Immunol 1992;27:171–9
   PubMed Web of Science ®Google Scholar
• Botsis D, Vrachnis N, Christodoulakos G. Doppler assessment of the intrauterine growth-restricted fetus. Ann N Y Acad Sci 2006;1092:297–303
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Vitoratos N, Iliodromiti Z, et al. Intrauterine inflammation and preterm delivery. Ann N Y Acad Sci 2010;1205:118–22
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Vrachnis N, Samoli E, et al. Investigation of midtrimester amniotic fluid factors as potential predictors of term and preterm deliveries. Mediators Inflamm 2006;2006:94381
   PubMed Web of Science ®Google Scholar
• Khalil A, Muttukrishna S, Harrington K, et al. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders. PLoS ONE 2008;3:e2766
   PubMed Web of Science ®Google Scholar
• Poole TJ, Coffin JD. Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J Exp Zool 1989;251:224–31
   PubMedGoogle Scholar
• Guo S, Colbert LS, Fuller M, et al. Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta 2010;1806:108–21
   PubMed Web of Science ®Google Scholar
• Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73–91
   PubMed Web of Science ®Google Scholar
• Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997;173:206–10
   PubMed Web of Science ®Google Scholar
• Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999;13:1055–66
   PubMed Web of Science ®Google Scholar
• Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 2010;10:505–14
   PubMed Web of Science ®Google Scholar
• Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008;8:604–17
   PubMed Web of Science ®Google Scholar
• Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8:618–31
   PubMed Web of Science ®Google Scholar
• Vincent KA, Shyu KG, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000;102:2255–61
   PubMed Web of Science ®Google Scholar
• King BF. Ultrastructural differentiation of stromal and vascular components in early macaque placental villi. Am J Anat 1987;178:30–44
   PubMedGoogle Scholar
• Zeng G, Taylor SM, McColm JR, et al. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood 2007;109:1345–52
   PubMed Web of Science ®Google Scholar
• Breunis WB, Davila S, Shimizu C, et al. International Kawasaki Disease Genetics Consortium. Disruption of vascular homeostasis in Kawasaki Disease patients: involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum 2012;64:306–15
   PubMedGoogle Scholar
• Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am J Reprod Immunol 2004;51:257–68
   PubMed Web of Science ®Google Scholar
• Koch S, Tugues S, Li X, et al. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011;437:169–83
   PubMed Web of Science ®Google Scholar
• De Vries C, Escobedo JA, Ueno H, et al. The Fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989–91
   PubMed Web of Science ®Google Scholar
• Matthews W, Jordan CT, Gavin M, et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991;88:9026–30
   PubMed Web of Science ®Google Scholar
• Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (Flt) closely related to the Fms family. Oncogene 1993;5:519–24
   Google Scholar
• Albuquerque RJ, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nature Med 2009;15:1023–30
   PubMed Web of Science ®Google Scholar
• Wallner W, Sengenberger R, Strick R. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007;112:51–7
   PubMed Web of Science ®Google Scholar
• Ahmad S, Hewett PW, Al-Ani B, et al. Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. Vasc Cell 2011;3:15
   PubMedGoogle Scholar
• McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell 1993;73:421–4
   PubMed Web of Science ®Google Scholar
• Vihinen PP, Ramadan S, Vuoristo MS, et al. Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab. Melanoma Res 2011;21:431–7
   PubMed Web of Science ®Google Scholar
• Shiraishi S, Nakagawa K, Kinukawa N, et al. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996;17:111–21
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Raheja S, Tuli A, et al. Serum PlGF as a potential biomarker for predicting the onset of preeclampsia. Arch Gynecol Obstet 2011;285:417–22
   PubMed Web of Science ®Google Scholar
• Maglione D, Guerriero V, Viglietto G, et al. Two alternative messenger-RNAs coding for the angiogenic factor, placenta growth-factor (PlGF), are transcribed from a single gene of chromosome-14. Oncogene 1993;8:925–31
   PubMed Web of Science ®Google Scholar
• Maglione D, Guerriero V, Viglietto G, et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991;88:9267–71
   PubMed Web of Science ®Google Scholar
• Iyer S, Leonidas DD, Swaminathan GJ, et al. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem 2001;276:12153–61
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996;271:3154–62
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657–65
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997;56:489–94
   PubMed Web of Science ®Google Scholar
• Odorisio T, Cianfarani F, Failla CM, Zambruno G. The placenta growth factor in skin angiogenesis. J Dermatol Sci 2006;41:11--19
   PubMed Web of Science ®Google Scholar
• Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993;9:259–68
   PubMed Web of Science ®Google Scholar
• Ziche M, Maglione D, Ribatti D, et al. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab Invest 1997;76:517–31
   PubMed Web of Science ®Google Scholar
• Parelman N, Selvaraj SK, Batra S, et al. Placenta growth factor activates monocytes ABD correlates in sickle cell disease severity. Blood 2003;102:1506–14
   PubMed Web of Science ®Google Scholar
• Seung-Ah Y, Hyung-Ju Y, Hyun-Sook K, et al. Role of placenta growth factor and its receptor Flt-1 in rheumatoid inflammation. Arthritis Rheum 2009;60:345–54
   PubMedGoogle Scholar
• Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951–62
   PubMed Web of Science ®Google Scholar
• Ferrara NH, Gerber P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–76
   PubMed Web of Science ®Google Scholar
• Yoo SA, Bae DG, Ryoo JW, et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-a and IL-6 by human monocytes. J Immunol 2005; 174:5846–55
   PubMed Web of Science ®Google Scholar
• Oura H, Bertoncini J, Velasco P, et al. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 2003;101:560–7
   PubMed Web of Science ®Google Scholar
• Selvaraj SK, Giri RK, Parelman N, et al. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003;102:1515–24
   PubMed Web of Science ®Google Scholar
• Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen: a review. Placenta 2000;21:16–24
   PubMed Web of Science ®Google Scholar
• Khaliq A, Dunk C, Jiang J, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab Invest 1999;79:151–70
   PubMed Web of Science ®Google Scholar
• Thieme H, Aiello LP, Takagi H, et al. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1993;44:98–103
   Web of Science ®Google Scholar
• Taylor CM, Stevens H, Anthony FW, Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. Placenta 1997;18:451–8
   PubMed Web of Science ®Google Scholar
• Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992;6:886–92
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442–7
   PubMed Web of Science ®Google Scholar
• Demir R, Kaufmann P, Castellucci M, et al. Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat (Basel) 1989;136:190–203
   PubMedGoogle Scholar
• Asan E, Kaymaz FF, Cakar AN, et al. Vasculogenesis in early human placental villi: an ultrastructural study. Anat Anz 1999;181:549–54
   Google Scholar
• Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004;11:342–52
   PubMedGoogle Scholar
• Higgins M, McAuliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev 2010;6:116–25
   PubMedGoogle Scholar
• Malamitsi-Puchner A, Economou E, Boutsikou T, et al. Neurotrophin-3 and FLT3 tyrosine kinase receptor in perinatal life. Mediators Inflamm 2005;2005:53–6
   PubMedGoogle Scholar
• Muetze S, Kapagerof A, Vlachopoulos L, et al. Mutation analysis of the growth factor genes PlGF, Flt1, IGF-I, and IGF-IR in intrauterine growth restriction with abnormal placental blood flow. J Matern Fetal Neonatal Med 2010;23:142–7
   PubMed Web of Science ®Google Scholar
• Myatt L. Role of placenta in preeclampsia. Endocrine 2002;19:103–11
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1–7
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky OH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152–64
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970–5
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011;24:1187–207
   PubMed Web of Science ®Google Scholar
• Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287:3183–6
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 2012;25:498–507
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Botsis D, Iliodromiti Z. The fetus that is small for gestational age. Ann N Y Acad Sci 2006;1092:304–9
   PubMed Web of Science ®Google Scholar
• Su YN, Lee ON, Oheng WF, et al. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001;97:898–904
   PubMed Web of Science ®Google Scholar
• Tidwell SO, Ho HN, Ohiu WH, et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267–72
   PubMed Web of Science ®Google Scholar
• Teixeira PG, Oabral AO, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008;27:65–73
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Ohaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021–38
   PubMed Web of Science ®Google Scholar
• Moore AG, Young H, Keller JM, et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J Matern Fetal Neonatal Med 2012;25:2651--7
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911–19
   PubMed Web of Science ®Google Scholar
• Vandenberghe G, Mensink I, Twisk JW, et al. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia. Prenat Diagn 2011;31:955–61
   PubMed Web of Science ®Google Scholar
• Tjoa ML, van Vugt JM, Mulders MA, et al. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600–7
   PubMed Web of Science ®Google Scholar
• Staff AC, Harsem NK, Braekke K, et al. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies. Eur J Obstet Gynecol Reprod Biol 2009;143:29–33
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177–82
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770–5
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008;28:1110–15
   PubMed Web of Science ®Google Scholar
• Cowans NJ, Stamatopoulou A, Matwejew E, et al. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn 2010;30:565–70
   PubMed Web of Science ®Google Scholar
• Kalampokas E, Vrachnis N, Samoli E, et al. Association of adiponectin and placental growth factor in amniotic fluid with second trimester fetal growth. In Vivo 2012;26:327–33
   PubMed Web of Science ®Google Scholar